Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2018200736) FORMULATIONS FOR EXTENDING LIFESPAN AND HEALTHSPAN
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2018/200736 International Application No.: PCT/US2018/029455
Publication Date: 01.11.2018 International Filing Date: 25.04.2018
IPC:
A61K 31/4745 (2006.01) ,A61K 31/19 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
435
having six-membered rings with one nitrogen as the only ring hetero atom
47
Quinolines; Isoquinolines
4738
ortho- or peri-condensed with heterocyclic ring systems
4745
condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenanthrolines
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
185
Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
19
Carboxylic acids, e.g. valproic acid
Applicants:
THE BUCK INSTITUTE FOR RESEARCH ON AGING [US/US]; 8001 Redwood Blvd. Novato, CA 94945, US
Inventors:
KENNEDY, Brian; US
LITHGOW, Gordon, J.; US
WELDON, Thomas; US
EDGAR, Daniel; US
LUCANIC, Mark; US
Agent:
MCNAMARA, Laurie, K.; US
Priority Data:
62/489,88425.04.2017US
62/646,73422.03.2018US
Title (EN) FORMULATIONS FOR EXTENDING LIFESPAN AND HEALTHSPAN
(FR) FORMULATIONS POUR PROLONGER LA DURÉE DE VIE ET LA DURÉE DE VIE EN SANTÉ
Abstract:
(EN) Described herein are compositions for delaying onset or delaying progression of frailty, reversing aging phenotype, extending healthspan, compressing morbidity, increasing lifespan and reducing formation of senescent cells.
(FR) La présente invention concerne des compositions permettant de retarder l'apparition ou de retarder la progression de la fragilité, d'inverser le phénotype du vieillissement, de prolonger la durée de vie en santé, de juguler la morbidité, d'augmenter la durée de vie et de réduire la formation de cellules sénescentes.
front page image
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)